Related Experiment Videos

Purification and properties of the gp340 component of Epstein-Barr virus membrane antigen in an immunogenic form

Insights

Researchers purified Epstein-Barr virus (EBV) membrane antigen (MA) using preparative SDS-polyacrylamide gel electrophoresis, achieving a 50-fold increase in recovery. The purified gp340 antigen is suitable for developing an EBV vaccine.

Area of Science:

  • Virology
  • Immunology
  • Biochemistry

Background:

  • Epstein-Barr virus (EBV) is a human herpesvirus associated with various malignancies.
  • EBV-determined membrane antigen (MA) is a key target for immune responses against EBV infection.
  • Efficient purification of MA is crucial for developing diagnostic tools and vaccines.

Purpose of the Study:

  • To develop an improved method for purifying the gp340 component of EBV-MA.
  • To assess the suitability of the purified gp340 for vaccine development.

Main Methods:

  • Preparative SDS-polyacrylamide gel electrophoresis (PAGE) for gp340 purification from B95-8 marmoset lymphoblastoid cells.
  • Cell culture optimization using 12-O-tetradecanoyl-phorbol-13-acetate (TPA) to enhance gp340 yield.
  • Renaturation of purified gp340.
  • Gel filtration chromatography to analyze MA component association.
  • Rabbit immunization with purified gp340 to generate specific antisera.

Main Results:

  • A 50-fold increase in gp340 recovery was achieved compared to conventional methods.
  • Successful renaturation of purified gp340 was accomplished.
  • TPA treatment of B95-8 cells resulted in an eightfold improvement in gp340 yield.
  • Antigenic sites on MA are primarily located on the protein portion.
  • Gel filtration indicated that MA polypeptide components are not associated in detergent solution.
  • High-titre, gp340-specific antisera were generated in rabbits.

Conclusions:

  • Preparative SDS-PAGE is an effective method for purifying EBV gp340.
  • The purified and renatured gp340 antigen is immunogenic and suitable for further evaluation as an experimental EBV vaccine.
  • Optimizing cell culture conditions can significantly enhance antigen yield.

Related Concept Videos